Computational evaluation of natural compounds as potential inhibitors of human PEPCK-M: an alternative for lung cancer therapy

scientific article published on 07 August 2019

Computational evaluation of natural compounds as potential inhibitors of human PEPCK-M: an alternative for lung cancer therapy is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.2147/AABC.S197119
P932PMC publication ID6689533
P698PubMed publication ID31496750

P50authorLaurent Emmanuel DardenneQ59687511
Vanessa Vc SinattiQ93185204
P2093author name stringAna Carolina Guimarães
Joao Hm Da Silva
Luiz Phillippe R Baptista
P2860cites workAn analysis of FDA-approved drugs: natural products and their derivatives.Q53629544
3‐Mercaptopicolinic acid, a preferential inhibitor of the cytosolic phosphoenolpyruvate carboxykinaseQ67384435
Prediction of drug absorption using multivariate statisticsQ73126791
Cancer Cells Hijack Gluconeogenic Enzymes to Fuel Cell GrowthQ86756788
Crystal structure of human cytosolic phosphoenolpyruvate carboxykinase reveals a new GTP-binding siteQ24292320
MolProbity: all-atom structure validation for macromolecular crystallographyQ24649111
Very fast prediction and rationalization of pKa values for protein-ligand complexesQ27144110
Structures of rat cytosolic PEPCK: insight into the mechanism of phosphorylation and decarboxylation of oxaloacetic acidQ27647056
Differential inhibition of cytosolic PEPCK by substrate analogues. Kinetic and structural characterization of inhibitor recognitionQ27649538
ZINC--a free database of commercially available compounds for virtual screeningQ27656255
The Ω-Loop Lid Domain of Phosphoenolpyruvate Carboxykinase Is Essential for Catalytic FunctionQ27674982
Inhibition and Allosteric Regulation of Monomeric Phosphoenolpyruvate Carboxykinase by 3-Mercaptopicolinic AcidQ27702033
Three-dimensional structure of rat acid phosphatase in complex with L(+)-tartrateQ27732059
Crystal structure of Escherichia coli phosphoenolpyruvate carboxykinase: a new structural family with the P-loop nucleoside triphosphate hydrolase foldQ27732635
Structural origins of L(+)-tartrate inhibition of human prostatic acid phosphataseQ27765889
Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settingsQ27861111
ClassyFire: automated chemical classification with a comprehensive, computable taxonomyQ27902281
PubChem Substance and Compound databasesQ27942588
PCK2 activation mediates an adaptive response to glucose depletion in lung cancerQ28235954
Mitochondrial phosphoenolpyruvate carboxykinase (PEPCK-M) is a pro-survival, endoplasmic reticulum (ER) stress response gene involved in tumor cell adaptation to nutrient availabilityQ28242891
Structural insights into the mechanism of PEPCK catalysisQ28250327
Assessment of protein models with three-dimensional profilesQ28283805
Inhibition of Pig Phosphoenolpyruvate Carboxykinase Isoenzymes by 3-Mercaptopicolinic Acid and Novel InhibitorsQ28552510
Hypoxia--a key regulatory factor in tumour growthQ29547318
Statistical potential for assessment and prediction of protein structuresQ29615145
Verification of protein structures: patterns of nonbonded atomic interactionsQ29615613
Charting biologically relevant chemical space: a structural classification of natural products (SCONP)Q30351855
Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015.Q30353189
PrediSi: prediction of signal peptides and their cleavage positionsQ31081611
Interactive exploration of chemical space with Scaffold HunterQ33475598
Pharmer: efficient and exact pharmacophore searchQ33909006
Screening of well-established drugs targeting cancer metabolism: reproducibility of the efficacy of a highly effective drug combination in miceQ33927565
Molecular properties that influence the oral bioavailability of drug candidatesQ34130727
DecoyFinder: an easy-to-use python GUI application for building target-specific decoy sets.Q34249296
Metabolic determinants of cancer cell sensitivity to glucose limitation and biguanides.Q34412152
Computer-based de novo design of drug-like moleculesQ34438895
Chemistry and biochemistry of (-)-hydroxycitric acid from Garcinia.Q34469262
PCK1 and PCK2 as candidate diabetes and obesity genesQ34654770
FAF-Drugs3: a web server for compound property calculation and chemical library design.Q35604907
Cutting the cost of drug development?Q35732868
ZINCPharmer: pharmacophore search of the ZINC databaseQ36088378
PEPCK Coordinates the Regulation of Central Carbon Metabolism to Promote Cancer Cell GrowthQ36307664
Inhibitory effect of traditional oriental medicine-derived monoamine oxidase B inhibitor on radioresistance of non-small cell lung cancerQ36611260
What is the metabolic role of phosphoenolpyruvate carboxykinase?Q37447862
Structural insights into the mechanism of phosphoenolpyruvate carboxykinase catalysisQ37564716
Understanding the Effectiveness of Natural Compound Mixtures in Cancer through Their Molecular Mode of Action.Q37729331
Molecular aptamers for drug deliveryQ37912756
Non-small-cell lung cancers: a heterogeneous set of diseasesQ38233321
Mitochondrial Phosphoenolpyruvate Carboxykinase Regulates Metabolic Adaptation and Enables Glucose-Independent Tumor Growth.Q38827417
Counting on natural products for drug designQ38843130
systemsDock: a web server for network pharmacology-based prediction and analysisQ40774775
Comparative Protein Structure Modeling Using MODELLER.Q41144462
Directory of useful decoys, enhanced (DUD-E): better ligands and decoys for better benchmarkingQ42251037
P275copyright licenseCreative Commons Attribution-NonCommercial 3.0 UnportedQ18810331
P6216copyright statuscopyrightedQ50423863
P304page(s)15-32
P577publication date2019-08-07
P1433published inAdvances and Applications in Bioinformatics and ChemistryQ4686376
P1476titleComputational evaluation of natural compounds as potential inhibitors of human PEPCK-M: an alternative for lung cancer therapy
P478volume12

Search more.